The fusion of anti-mesothelin Fv (SS1) with PE38 [SS1(dsFv)PE38] has been efficiently used to target mesothelin, a 40-kD tumor differentiation antigen [158] (Table 5). The gene discussed is MSLN; the disease is neoplasm.